JPMorgan’s second-quarter profit fell to $14.2 billion in second quarter, but the New York bank beat Wall Street expectations ...

JPMorgan’s second-quarter profit fell to $14.2 billion in second quarter, but the New York bank beat Wall Street expectations ...

Enphase Energy (NASDAQ:ENPH) -4.7% in Tuesday's trading as J.P. Morgan downgraded shares to Neutral from Overweight with a ...

JPMorgan’s second-quarter profit fell to $14.2 billion in second quarter, but the New York bank beat Wall Street expectations ...

J.P. Morgan’s U.S. equity research analysts compiled their list of “most compelling structural and tactical short ideas” for ...

Wall Street analysts are often criticized for being preternaturally upbeat. Buy ratings for top companies are abundant, and ...

Fintel reports that on July 15, 2025, JP Morgan upgraded their outlook for Otis Worldwide (NYSE:OTIS) from Neutral to ...

The Nasdaq Composite advanced to its latest record high on Tuesday, powered by a jump in heavyweight Nvidia's shares, while ...

JP Morgan CEO Jamie Dimon warned that President Trump's trade policies may pose significant risks to the US economy. He highlighted ongoing concerns related to tariffs, trade uncertainty, and ...

Island, the Enterprise Browser company, announced the participation of J.P. Morgan Private Capital's Growth Equity Partners as a strategic investor in its previously announced Series E funding round.

JP Morgan maintains its Overweight rating on Vedanta Resources despite governance concerns raised by a third-party report.

Telix Pharmaceuticals shares have one of the best 5 year track records on the ASX. Can this continue according to JP Morgan?